Scinai Immunotherapeutics to Host Webinar on Novel Monoclonal Antibody for Rare Skin Conditions
Scinai Immunotherapeutics to host webinar discussing PC111 monoclonal antibody for rare skin conditions. Learn about collaboration with Pincell and development plans. Impactful insights for patients and investors.
This news matters as it highlights the collaboration between Scinai Immunotherapeutics and Pincell to address unmet medical needs in rare skin conditions. The webinar provides insights into the development plans for PC111, offering hope for patients suffering from Pemphigus Vulgaris and SJS/TEN.
